13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001535610
Total reported value
$110.5M
$110.5M
39 檔
60.1%
In Q2 2024, Sabby Management, LLC's U.S. equity holdings reached a combined market value of $110.5M, distributed across 39 disclosed stock positions.
During Q2 2024, Sabby Management, LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Ishares Tr | Stock-Other | 69.42% | +11.16% | -2.56% | |
| 2 | ✓ | Ishares Tr | Stock-Other | 8.13% | +12.02% | NEW | |
| 3 | ✓ | Core Scientific Inc New | Stock-Other | 7.49% | — | — | |
| 4 | VANI | Vivani Medical Inc | Stock-Other | 3.65% | — | -20.46% | |
| 5 | ✓ | Bit Digital Inc | Stock-Other | 1.87% | — | +163.65% | |
| 6 | CORZW | Core Scientific Inc - 27 | Stock-Other | 1.04% | — | — | |
| 7 | ✓ | Spdr S&P 500 Etf Tr Put Option | ETF-Large Cap & Growth | 0.81% | +45.73% | -5.20% | |
| 8 | ✓ | Checkpoint Therapeutics Inc | Stock-Other | 0.79% | — | +14.12% | |
| 9 | RDHL | Redhill Biopharma Ltd-sp Adr | Stock-Other | 0.68% | — | -42.17% | |
| 10 | CORZ | Core Scientific, Inc. | Stock-Tech | 0.63% | — | — | |
| 11 | ✓ | Greenwave Technology Solutio | Stock-Other | 0.55% | — | — | |
| 12 | ✓ | Eltek LTD | Stock-Other | 0.54% | — | -64.10% | |
| 13 | IWM | Ishares Russell 2000 ETF | ETF-Small Cap | 0.41% | — | — | |
| 14 | ✓ | Reviva Pharmaceutcls Hldgs I | Stock-Other | 0.41% | — | — | |
| 15 | ✓ | Biovie Inc | Stock-Other | 0.40% | — | +6.37% | |
| 16 | ✓ | Stock-Other | 0.33% | — | +116.19% | ||
| 17 | ✓ | Stock-Other | 0.30% | — | — | ||
| 18 | SIDU | Sidus Space Inc-cl A | Stock-Other | 0.26% | +0.11% | NEW | |
| 19 | SPY | State Street SPDR S&P 500 ETF Trust | ETF-Large Cap & Growth | 0.23% | +13.85% | NEW | |
| 20 | ✓ | Ensysce Biosciences Inc | Stock-Other | 0.22% | — | +36.35% | |
| 21 | ✓ | Aptevo Therapeutics Inc | Stock-Other | 0.21% | — | — | |
| 22 | GEVO | Gevo Inc | Stock-Other | 0.19% | — | -28.57% | |
| 23 | NEXI | Neximmune Inc | Stock-Other | 0.19% | — | -16.62% | |
| 24 | ATXI | Avenue Therapeutics Inc | Stock-Other | 0.18% | — | — | |
| 25 | ✓ | Nrx Pharmaceuticals Inc | Stock-Other | 0.18% | — | — | |
| 26 | EFTR | Effector Therapeutics Inc | Stock-Other | 0.14% | — | — | |
| 27 | SMFL | Smart For Life Inc | Stock-Other | 0.14% | — | — | |
| 28 | ✓ | China Natural Resources Inc | Stock-Other | 0.11% | — | -75.55% | |
| 29 | ✓ | Inmed Pharmaceuticals Inc | Stock-Other | 0.11% | — | -15.06% | |
| 30 | ✓ | Gevo Inc | Stock-Other | 0.10% | — | +282.37% | |
| 31 | ✓ | Eos Energy Enterprises Inc | Stock-Other | 0.09% | — | +0.20% | |
| 32 | SCNI | Scinai Immunotherapeutics Lt | Stock-Other | 0.07% | — | — | |
| 33 | ✓ | Applied Dna Sciences Inc | Stock-Other | 0.04% | — | — | |
| 34 | SXTPW | 60 Degrees Pharma Inc-28 | Stock-Other | 0.03% | — | -3.63% | |
| 35 | ✓ | Globus Maritime Limited New | Stock-Other | 0.02% | — | -93.75% | |
| 36 | ✓ | Wearable Devices LTD | Stock-Other | 0.02% | — | -38.93% | |
| 37 | AMPGW | Amplitech Group Inc-cw26 | Stock-Other | 0.02% | — | -12.22% | |
| 38 | ✓ | Stock-Other | 0.01% | — | — | ||
| 39 | CINGW | Cingulate -cw23 | Stock-Other | 0.01% | — | -2.18% |
According to official SEC Form 13F filings, Sabby Management, LLC reported a total U.S. public equity portfolio value of $110.5M across 39 disclosed positions in Q2 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ISHARES TR, ISHARES TR, CORE SCIENTIFIC INC NEW) accounted for 60.1% of total reported equity market value during Q2 2024.
During Q2 2024, Sabby Management, LLC's top holdings by market value included ISHARES TR (69.4%)、ISHARES TR (8.1%)、CORE SCIENTIFIC INC NEW (7.5%). The largest single position, ISHARES TR, represented 69.4% of total portfolio value.
In Q2 2024, Sabby Management, LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.